ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,251, issued on Sept. 2, was assigned to Cerepeut Inc. (Stanford, Calif.).
"Small molecule compound" was invented by Bingwei Lu (Stanford, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions and methods for the treatment of cancer and other diseases associated with mitochondrial dysfunction, including but not limited to, neurodegenerative disease, brain injuries, and certain non-neurological disorders, using a novel compound, 6-chloro-3-(2,4-dichloro-5-methoxyphenyl)-2-mercapto-7-methoxyquinazolin-4(3H)-one, and derivatives thereof."
The patent was filed on Feb. 26, 2024, under Application No. 18/587,7...